These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20414155)

  • 1. Mood stabilizers in the treatment of substance use disorders.
    Maremmani I; Pacini M; Lamanna F; Pani PP; Perugi G; Deltito J; Salloum IM; Akiskal H
    CNS Spectr; 2010 Feb; 15(2):95-109. PubMed ID: 20414155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
    Camacho A; Akiskal HS
    J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pregnenolone for cognition and mood in dual diagnosis patients.
    Osuji IJ; Vera-Bolaños E; Carmody TJ; Brown ES
    Psychiatry Res; 2010 Jul; 178(2):309-12. PubMed ID: 20493557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Divalproex sodium in substance abusers with mood disorder.
    Albanese MJ; Clodfelter RC; Khantzian EJ
    J Clin Psychiatry; 2000 Dec; 61(12):916-21. PubMed ID: 11206596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does comorbid alcohol and substance abuse affect electroconvulsive therapy outcome in the treatment of mood disorders?
    Moss L; Vaidya N
    J ECT; 2014 Mar; 30(1):22-5. PubMed ID: 23859979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug abuse and bipolar disorder: comorbidity or misdiagnosis?
    Sherwood Brown E; Suppes T; Adinoff B; Rajan Thomas N
    J Affect Disord; 2001 Jul; 65(2):105-15. PubMed ID: 11356233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the prescription of mood stabilizers for adolescents: A literature review].
    Munch G; Godart N
    Encephale; 2017 Oct; 43(5):464-470. PubMed ID: 27871720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment.
    Wada K; Yamada N; Suzuki H; Lee Y; Kuroda S
    J Clin Psychiatry; 2000 Apr; 61(4):261-7. PubMed ID: 10830146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A history of substance abuse complicates remission from acute mania in bipolar disorder.
    Goldberg JF; Garno JL; Leon AC; Kocsis JH; Portera L
    J Clin Psychiatry; 1999 Nov; 60(11):733-40. PubMed ID: 10584760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment and treatment of mood disorders in the context of substance abuse.
    Tolliver BK; Anton RF
    Dialogues Clin Neurosci; 2015 Jun; 17(2):181-90. PubMed ID: 26246792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders.
    Akiskal HS; Bourgeois ML; Angst J; Post R; Möller H; Hirschfeld R
    J Affect Disord; 2000 Sep; 59 Suppl 1():S5-S30. PubMed ID: 11121824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
    Potvin S; Stip E; Roy JY
    Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiepileptic drugs as mood stabilizers: what did we learn from the epileptology?].
    Rajna P
    Ideggyogy Sz; 2008 Sep; 61(9-10):305-16. PubMed ID: 18841650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of affective temperaments and psychopathological traits on the definition of bipolar disorder subtypes: a study on bipolar I Italian national sample.
    Perugi G; Toni C; Maremmani I; Tusini G; Ramacciotti S; Madia A; Fornaro M; Akiskal HS
    J Affect Disord; 2012 Jan; 136(1-2):e41-e49. PubMed ID: 20129674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overdiagnosis of bipolar disorder among substance use disorder inpatients with mood instability.
    Goldberg JF; Garno JL; Callahan AM; Kearns DL; Kerner B; Ackerman SH
    J Clin Psychiatry; 2008 Nov; 69(11):1751-7. PubMed ID: 18945397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of bipolar spectrum conditions in the comorbidity of mood and substance use disorders: results from the Zurich cohort study.
    Merikangas KR; Herrell R; Swendsen J; Rössler W; Ajdacic-Gross V; Angst J
    Arch Gen Psychiatry; 2008 Jan; 65(1):47-52. PubMed ID: 18180428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a unitary perspective on the bipolar spectrum and substance abuse: opiate addiction as a paradigm.
    Maremmani I; Perugi G; Pacini M; Akiskal HS
    J Affect Disord; 2006 Jul; 93(1-3):1-12. PubMed ID: 16675028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry.
    Maremmani I; Maremmani AG; Rugani F; Rovai L; Pacini M; Bacciardi S; Deltito J; Dell'osso L; Akiskal HS
    Ann Gen Psychiatry; 2012 Sep; 11(1):23. PubMed ID: 22943591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.